Fox Chase Researchers Present Findings on BRCA-Mutated Breast Cancer at American Society for Radiation Oncology Meeting
PHILADELPHIA (October 2, 2023) — The presence of BRCA1 and BRCA2 mutations in breast cancer patients did not predict improved survival for patients who received radiation therapy, according to findings presented by Fox Chase Cancer Center researchers recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego.